SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing

• Riccardo Mezzadra ,

  Contributed equally to this work with: Riccardo Mezzadra, Marjolein de Bruijn

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Validation, Writing – original draft

  Affiliation Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  http://orcid.org/0000-0002-7737-8461

  ⨯
• Marjolein de Bruijn ,

  Contributed equally to this work with: Riccardo Mezzadra, Marjolein de Bruijn

  Roles Investigation, Validation

  Affiliation Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Lucas T. Jae,

  Roles Data curation, Formal analysis, Investigation

  Current address: Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.

  Affiliation Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Raquel Gomez-Eerland,

  Roles Investigation

  Affiliation Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Anja Duursma,

  Roles Formal analysis, Investigation

  Affiliation Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯
• Ferenc A. Scheeren,

  Roles Investigation, Supervision

  Current address: Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.

  Affiliation Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  http://orcid.org/0000-0002-8304-9023

  ⨯
• Thijn R. Brummelkamp,

  Roles Supervision

  Affiliations Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria, Cancergenomics.nl, Amsterdam, The Netherlands

  ⨯
• Ton N. Schumacher

  Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft

  * E-mail: t.schumacher@nki.nl

  Affiliation Division of Molecular Oncology & Immunology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands

  ⨯